Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
May 10, 2021
IDEAYA Announces Dose Expansion in Phase 1/2 Study of Darovasertib and Crizotinib Combination based on Early Clinical Efficacy in First Combination Cohort
May 7, 2021
Akouos Appoints Dr. Kathy Reape as Chief Development Officer
May 4, 2021
Escient Pharmaceuticals Names Svetlana Makhni As Chief Financial Officer
May 4, 2021
Entrada Therapeutics Appoints Biotech Industry Leader Mary Thistle to Its Board of Directors
May 3, 2021
Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
April 28, 2021
Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs at the American Society of Gene and Cell Therapy 24th Annual Meeting
April 28, 2021
Homology Medicines Announces New Approach to Leverage AAVHSC Platform by Delivering One-Time In Vivo Gene Therapy to Produce Antibodies in Humanized Murine Model
April 23, 2021
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering
April 22, 2021
Pear Announces Ohio Department of Mental Health and Addiction Services Will Provide Access to Prescription Digital Therapeutics to Help Local Communities Continue to Fight Against Opioid Addiction
April 21, 2021
Northwell Health Teams with Pear Therapeutics to Provide New Treatment for Patients with Substance Use Disorders
« Previous Page
1
…
7
8
9
10
11
…
16
Next Page »